FVR C-P VaccineThis page contains information on FVR C-P Vaccine for veterinary use.
The information provided typically includes the following:
- FVR C-P Vaccine Indications
- Warnings and cautions for FVR C-P Vaccine
- Direction and dosage information for FVR C-P Vaccine
Fvr C-p VaccineThis treatment applies to the following species:
Feline Rhinotracheitis-calici-panleukopenia Vaccine
Modified Live And Killed Virus
For veterinary use in cats only
FVR® C-P vaccine is a combination of antigens for convenient use in healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, feline calici and feline panleukopenia viruses. The feline rhinotracheitis-calici component is a lyophilized suspension of modified live viruses propagated in a stable cell line of feline origin and backfilled with an inert gas. The feline panleukopenia virus is propagated in a stable cell line of feline origin. The virus has been chemically inactivated and determined to be non-viricidal when used as a diluent to rehydrate the feline rhinotracheitis-calici vaccine. The safety and efficacy of each virus strain has been demonstrated by vaccination and challenge tests in healthy susceptible cats.
FVR C-P Vaccine Dosage And Administration
Transfer contents of the PANAGEN® vaccine vial to the FVR® C vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Prior To Use, Warm The Panagen® Vaccine To Room Temperature And Shake Well.
Two doses are required for primary immunization.
Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 8 to 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.
If the animal is less than 12 weeks of age, it should be revaccinated every 3 to 4 weeks until 12 to 16 weeks of age.
Annual revaccination with one dose is recommended.
Store at 2°-7°C.
Do not freeze.
Do not mix with other vaccines.
Use new, non-chemically sterilized needles and syringes.
Burn vaccine container and all unused contents.
Contains gentamicin and amphotericin B as preservatives.
Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
Do not vaccinate pregnant cats.
The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
AntidoteEpinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
U.S. Veterinary License No. 165A
Schering-Plough Animal Health Corporation, Omaha, Nebraska 68103 USA
1 800 224-5318 (USA)
1 888 306-0069 (Canada)
© Copyright 1999, 2001, 2006, Schering-Plough Animal Health Corp.
All rights reserved.
Distributed by INTERVET/SCHERING-PLOUGH ANIMAL HEALTH
29160 INTERVET LANE, P.O. BOX 318, MILLSBORO, DE, 19966-0318
|Every effort has been made to ensure the accuracy of the FVR C-P Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2013-12-23